Israeli healthcare-focused VC fund aMoon Partners has finalized $660 million in investor commitments for it second fund (aMoon II), making it the largest single fund in Israel. The fund, run by... read more
Israeli healthcare-focused VC fund aMoon Partners has finalized $660 million in investor commitments for it second fund (aMoon II), making it the largest single fund in Israel. The fund, run by... read more
Xenetic Biosciences, Inc. (NASDAQ: XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology... read more
On 3/4/19 Silk Road Medical Filed for an upcoming $86 Million IPO. The Sunnyvale, CA based company has introduced the TCAR procedure intended to reduce the risk embolic debris entering the brain... read more
Abpro, a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases, and NJCTTQ, a global... read more
BiomX Raises $32 Million in Series B Financing
BiomX Ltd., a microbiome company developing... read more